David T. Hickman

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy

Clara Theunis, Natàlia Crespo‐Biel, Valérie Gafner et al. · PLoS ONE · 2013 · 249 citations · Full text

Immunology, Tau.p301l Mice, Neuroinflammation +18

Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies

Heiko Kroth, Felix Oden, Jérôme Molette et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 213 citations · Full text

Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice

Andreas Muhs, David T. Hickman, Maria Pihlgren et al. · Proceedings of the National Academy of Sciences · 2007 · 174 citations · Full text

Immunology, Immunodominance, Antigen Processing +19

Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases

David T. Hickman, María Pilar López-Deber, Dorin Mlaki Ndao et al. · Journal of Biological Chemistry · 2011 · 82 citations · Full text

Proteinlipid Interaction, Peptide Engineering, Immunology +25

DyNAs: Constitutional Dynamic Nucleic Acid Analogues

Nampally Sreenivasachary, David T. Hickman, Dominique Sarazin et al. · Chemistry - A European Journal · 2006 · 59 citations

Dynamic Cationic Polymers, Engineering, Molecular Biology +16